Price of giritinib tablets in 2024
Giritinib tablets, this targeted therapy drug, has shown remarkable results in the treatment of patients with relapsed or refractory acute myeloid leukemia (AML) with FLT3 mutations in recent years, and has therefore attracted much attention from the medical community and patients. As time goes by, the price of gilitinib tablets has gradually become a hot topic of public concern.
In 2024, the price of gilitinib tablets in the domestic market will remain roughly at more than 20,000 yuan per box. This price is relatively high, but considering its unique efficacy and specificity, it is still a worthwhile choice for patients who need this drug. However, with the intensification of market competition and policy adjustments, the price of gilitinib tablets may change in the future.

In overseas markets, the price of gilitinib tablets varies due to regional differences. For example, in the European market, its price may be as high as hundreds of thousands of yuan, while in the Hong Kong market, its original drug is priced at around 90,000 yuan. These price differences are mainly due to factors such as economic development levels, medical policies, and drug distribution channels in different regions. However, for domestic patients, there are certain risks in purchasing drugs overseas, so be sure to choose formal channels and consult professional medical institutions or experts when using them.
It is worth mentioning that the rise of generic drugs in recent years has brought more affordable options to patients. Some countries have approved the marketing of generic drugs of giritinib tablets. These generic drugs have the same ingredients as the original drug, but are more affordable. For example, in countries such as Laos, the price of generic giritinib tablets is about three to four thousand yuan, providing patients with a more economical treatment option. However, patients should ensure the quality and safety of the drug when choosing to purchase gilitinib tablets. It is recommended to purchase through formal channels and consult a professional doctor or pharmacist for advice.xa0
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)